Skip to main content
. 2019 Feb 28;7(5):e14004. doi: 10.14814/phy2.14004

Table 1.

Baseline characteristics of study participants

Bariatric surgery Controls P‐value
Number of participants 69 33
Age, years 41.5 (11.1) 42.2 (10.3) 0.7
Men, n (%) 20 (29.0) 11 (32.4) 0.7
Statin users, n (%) 23 (33.3) 17 (54.8) <0.0001
Smokers, n (%) 13 (18.8) 8 (25.8) <0.0001
Type 2 diabetes, n (%) 34 (49.3) 10 (32.3) <0.0001
Body weight, kg 136.6 (26.4) 127.1 (28.4) 0.1
Body mass index, kg/m2 49.9 (7.0) 45.3 (7.6) 0.005
Fat percent, % 51.4 (5.5) 47.4 (6.2) 0.002
Fat mass, kg 70.6 (17.5) 59.9 (17.8) 0.006
Fat‐free mass, kg 66.0 (13.5) 66.1 (15.9) 0.9
LDL cholesterol, mmol/L 2.61 (0.72) 2.56 (0.87) 0.7
HDL cholesterol, mmol/L 1.27 (0.29) 1.16 (0.30) 0.1
Triglycerides, mmol/L 1.70 (1.07) 1.83 (0.75) 0.7
Apolipoprotein B, g/L 0.78 (0.19) 0.80 (0.20) 0.6
Insulin, pmol/L 199.4 (133.5) 175.5 (136.6) 0.4
Glucose, mmol/L 6.77 (2.40) 6.62 (2.91) 0.9
HOMA‐IR 8.92 (7.15) 7.79 (6.44) 0.4
HbA1c, % 6.24 (1.05) 6.45 (1.30) 0.3
Adiponectin, ng/mL 5414 (3531) 8969 (8382) 0.04
Leptin, pg/mL 69,354 (46,383) 43,559 (31,397) 0.003
Autotaxin, ng/mL 342.0 (156.1) 303.3 (146.0) 0.2

Data are presented as mean (±SD). LDL: low‐density lipoprotein; HDL: high‐density lipoprotein; HOMA‐IR: homeostatic model of insulin resistance; HbA1c: glycated hemoglobin.